OSEBX1,423.56+0.84%
EQNR284.60+4.20%
DNB198.35-1.15%
MOWI172.80+0.45%
Brent$71.24-0.32%
EUR/USD1.0824-0.14%
DXY104.18+0.08%
INDICATIVE · SAMPLE DATA
HHL.CM60

Hemas Holdings PLC

Consumer Goods ConglomeratesVerified

Hemas Holdings PLC maintains a conservative capital structure with a debt-to-equity ratio of 0.16, indicating a low reliance on debt financing. The company's liquidity position is characterized as medium, with a current ratio of 1.64, suggesting it can cover its short-term obligations but with limited excess capacity. However, the company's net cash position is negative after subtracting total debt, signaling potential liquidity constraints. In terms of profitability, Hemas Holdings PLC demonstrates a return on equity (ROE) of 16.19% and a return on assets (ROA) of 8.32%, which are strong indicators of efficient capital utilization and asset management. These metrics suggest the company is generating solid returns relative to its equity and asset base, outperforming many industry peers in terms of capital efficiency. The company's revenue is distributed across three primary segments: Consumer Brands, Healthcare, and Mobility and Other. The Consumer Brands segment offers a range of personal care and stationery products, while the Healthcare segment includes pharmaceutical distribution and hospital services. The Mobility segment is engaged in logistics and transportation services. However, the input data does not provide specific revenue concentration figures for each segment, making it difficult to assess geographic or segment-level exposure. Hemas Holdings PLC's growth trajectory is not explicitly detailed in the input data, but the company's operating cash flow of 13,387,969,000 LKR and free cash flow of 2,752,506,000 LKR suggest it has the capacity to fund operations and potentially reinvest in growth opportunities. The capital expenditure of -5,195,939,000 LKR indicates a reduction in capital spending, which may reflect a strategic shift or a response to market conditions. The company's risk profile is characterized by a medium liquidity risk and a low dilution risk. The negative net cash position after subtracting total debt is a key liquidity flag, indicating potential challenges in maintaining short-term liquidity. The low dilution risk suggests that the company is not currently under pressure to issue additional shares, which is supported by the absence of dilution-related adjustments in the valuation data. Recent events and filings do not provide specific details on recent corporate actions or strategic initiatives. However, the company's financial performance and risk profile suggest it is maintaining a stable position in its markets. The input data does not include recent transcripts or filings that would provide additional context on management's strategic direction or operational performance.

30-day price · HHL.CM+2.90 (+9.7%)
Low$29.50High$33.70Close$32.70As of15 May, 00:00 UTC
Profile
CompanyHemas Holdings PLC
TickerHHL.CM
SectorConsumer Non-Cyclicals
BusinessConsumer Goods Conglomerates
Industry groupConsumer Goods Conglomerates
IndustryConsumer Goods Conglomerates
AI analysis

Business. Hemas Holdings PLC is a Sri Lanka-based holding company engaged in investment activities and providing advisory services to other companies in the Hemas Group, with operations in consumer brands, healthcare, and mobility segments.

Classification. Hemas Holdings PLC is classified under the Consumer Non-Cyclicals economic sector, specifically in the Consumer Goods Conglomerates business sector, with a classification confidence of 0.92.

Hemas Holdings PLC maintains a conservative capital structure with a debt-to-equity ratio of 0.16, indicating a low reliance on debt financing. The company's liquidity position is characterized as medium, with a current ratio of 1.64, suggesting it can cover its short-term obligations but with limited excess capacity. However, the company's net cash position is negative after subtracting total debt, signaling potential liquidity constraints. In terms of profitability, Hemas Holdings PLC demonstrates a return on equity (ROE) of 16.19% and a return on assets (ROA) of 8.32%, which are strong indicators of efficient capital utilization and asset management. These metrics suggest the company is generating solid returns relative to its equity and asset base, outperforming many industry peers in terms of capital efficiency. The company's revenue is distributed across three primary segments: Consumer Brands, Healthcare, and Mobility and Other. The Consumer Brands segment offers a range of personal care and stationery products, while the Healthcare segment includes pharmaceutical distribution and hospital services. The Mobility segment is engaged in logistics and transportation services. However, the input data does not provide specific revenue concentration figures for each segment, making it difficult to assess geographic or segment-level exposure. Hemas Holdings PLC's growth trajectory is not explicitly detailed in the input data, but the company's operating cash flow of 13,387,969,000 LKR and free cash flow of 2,752,506,000 LKR suggest it has the capacity to fund operations and potentially reinvest in growth opportunities. The capital expenditure of -5,195,939,000 LKR indicates a reduction in capital spending, which may reflect a strategic shift or a response to market conditions. The company's risk profile is characterized by a medium liquidity risk and a low dilution risk. The negative net cash position after subtracting total debt is a key liquidity flag, indicating potential challenges in maintaining short-term liquidity. The low dilution risk suggests that the company is not currently under pressure to issue additional shares, which is supported by the absence of dilution-related adjustments in the valuation data. Recent events and filings do not provide specific details on recent corporate actions or strategic initiatives. However, the company's financial performance and risk profile suggest it is maintaining a stable position in its markets. The input data does not include recent transcripts or filings that would provide additional context on management's strategic direction or operational performance.
Key takeaways
  • Hemas Holdings PLC maintains a conservative capital structure with a low debt-to-equity ratio of 0.16.
  • The company's return on equity (16.19%) and return on assets (8.32%) indicate strong profitability and efficient capital utilization.
  • The company's liquidity position is characterized as medium, with a current ratio of 1.64, but a negative net cash position after subtracting total debt.
  • The company's growth trajectory is supported by positive operating and free cash flows, but capital expenditure has decreased.
  • The company's risk profile is characterized by medium liquidity risk and low dilution risk.
  • --
  • ## RATIONALES
  • ```json
Financial snapshot
PeriodHA-latest
CurrencyLKR
Revenue$117.97B
Gross profit$37.07B
Operating income$13.71B
Net income$8.06B
R&D
SG&A
D&A
SBC
Operating cash flow$13.39B
CapEx-$5.20B
Free cash flow$2.75B
Total assets$96.89B
Total liabilities$47.11B
Total equity$49.78B
Cash & equivalents$5.76B
Long-term debt$8.15B
Annual history (last 5)
PeriodRevenueOp IncomeNet IncomeFCF
FY0
FY-1
FY-2
FY-3
FY-4
PeriodGross %Op %Net %FCF %
FY0
FY-1
FY-2
FY-3
FY-4
PeriodAssetsEquityCashDebt
FY0
FY-1
FY-2
FY-3
FY-4
PeriodOCFCapExFCFSBC
FY0
FY-1
FY-2
FY-3
FY-4
Quarterly history (last 4)
PeriodRevenueOp IncomeNet IncomeFCF
FQ0
FQ-1
FQ-2
FQ-3
FQ-4
FQ-5
FQ-6
FQ-7
PeriodGross %Op %Net %FCF %
FQ0
FQ-1
FQ-2
FQ-3
FQ-4
FQ-5
FQ-6
FQ-7
PeriodAssetsEquityCashDebt
FQ0
FQ-1
FQ-2
FQ-3
FQ-4
FQ-5
FQ-6
FQ-7
PeriodOCFCapExFCFSBC
FQ0
FQ-1
FQ-2
FQ-3
FQ-4
FQ-5
FQ-6
FQ-7
Valuation
Market price
Market cap
Enterprise value
P/E
Reported non-GAAP P/E
EV/Revenue
EV/Op income
EV/OCF
P/B
P/Tangible book
Tangible book$49.78B
Net cash-$2.39B
Current ratio1.6
Debt/Equity0.2
ROA8.3%
ROE16.2%
Cash conversion1.7%
CapEx/Revenue-4.4%
SBC/Revenue
Asset intensity
Dilution ratio0.0%
Risk assessment
Dilution riskLow
Liquidity riskMedium
  • Net cash is negative after subtracting total debt.
Industry benchmarks
Activity: Consumer Goods Conglomerates · cohort 1 companies
MetricHHL.CMActivity
Op margin11.6%26.3% medp25 26.3% · p75 26.3%bottom quartile
Net margin6.8%6.9% medp25 2.3% · p75 18.0%below median
Gross margin31.4%24.7% medp25 20.8% · p75 31.5%above median
R&D / revenue1.9% medp25 1.9% · p75 1.9%
CapEx / revenue-4.4%2.6% medp25 2.6% · p75 2.6%bottom quartile
Debt / equity16.0%207.2% medp25 207.2% · p75 207.2%bottom quartile
Observations
IR observations
Mean price target38.30 LKR
Median price target38.30 LKR
High price target38.30 LKR
Low price target38.30 LKR
Mean recommendation2.00 (1=strong buy, 5=strong sell)
Strong-buy count0.00
Buy count1.00
Hold count0.00
Sell count0.00
Strong-sell count0.00
Mean EPS estimate3.00 LKR
Last actual EPS2.70 LKR
Source data
Underlying data the analysis-pipeline pulls and audits. Fetch timestamps + content hashes show when each source was last refreshed.
Company fundamentalsperiod FQ-7 · history via verified-market-data
no public URL
2026-05-04 14:36 UTC#f76c0f1a
Source: analysis-pipeline (hybrid)Generated: 2026-05-04 14:37 UTCJob: 7294b2e7